Investors



SEC Filings

Filing date Form Description Filing Group View
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

3,4,5
View HTML
424B4

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
F-1/A

This filing is a pre-effective amendment to an F-1 filing

Registration Statements
View HTML
CERTNAS

CERTNAS

Other
View HTML
F-1/A

This filing is a pre-effective amendment to an F-1 filing

Registration Statements
View HTML
F-1/A

This filing is a pre-effective amendment to an F-1 filing

Registration Statements
View HTML

Copyright Morningstar







© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
Macrilen is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V13 01/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
info@strongbridgebio.com

Privacy Statement
Compliance Program